Regadenoson is a selective A2A adenosine receptor agonist and vasodilator that increases coronary blood flow and is used in myocardial perfusion imaging studies; it also enhances blood-brain barrier (BBB) permeability in rodents and can be used to facilitate the delivery of centrally active molecules to the human central nervous system.